首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4252篇
  免费   312篇
  4564篇
  2022年   26篇
  2021年   47篇
  2020年   33篇
  2019年   40篇
  2018年   47篇
  2017年   42篇
  2016年   72篇
  2015年   145篇
  2014年   149篇
  2013年   230篇
  2012年   251篇
  2011年   245篇
  2010年   148篇
  2009年   133篇
  2008年   208篇
  2007年   196篇
  2006年   178篇
  2005年   195篇
  2004年   194篇
  2003年   182篇
  2002年   172篇
  2001年   111篇
  2000年   93篇
  1999年   114篇
  1998年   76篇
  1997年   52篇
  1996年   49篇
  1995年   52篇
  1994年   47篇
  1993年   58篇
  1992年   82篇
  1991年   78篇
  1990年   67篇
  1989年   63篇
  1988年   66篇
  1987年   54篇
  1986年   49篇
  1985年   55篇
  1984年   26篇
  1983年   49篇
  1982年   38篇
  1981年   37篇
  1980年   22篇
  1979年   36篇
  1978年   23篇
  1977年   31篇
  1975年   18篇
  1974年   22篇
  1973年   21篇
  1972年   25篇
排序方式: 共有4564条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
The effects of prostaglandin E1 (PGE1) on the phenotypic state of enzymatically isolated arterial smooth-muscle cells in primary culture were studied by transmission electron microscopy, thymidine autoradiography, and cell counting. Early in culture (day 0-2), PGE1 stimulated conversion of the cells from contractile (less euchromatic nucleus and cytoplasm dominated by myofilament bundles) to synthetic state (more euchromatic nucleus and cytoplasm dominated by cisternae of rough endoplasmic reticulum and a large Golgi complex). The rate of entrance of the cells into DNA synthesis and mitosis was also increased at this time. Later on (day 3-6), when the majority of the cells had entered synthetic state, PGE1 inhibited DNA synthesis and cellular proliferation. These observations indicate that the effect of prostaglandins on arterial smooth muscle is dual in nature and dependent on the state of differentiation of the cells.  相似文献   
5.
6.
7.
8.
Readouts that define the physiological distributions of drugs in tissues are an unmet challenge and at best imprecise, but are needed in order to understand both the pharmacokinetic and pharmacodynamic properties associated with efficacy. Here we demonstrate that it is feasible to follow the in vivo transport of unlabeled drugs within specific organ and tissue compartments on a platform that applies MALDI imaging mass spectrometry to tissue sections characterized with high definition histology. We have tracked and quantified the distribution of an inhaled reference compound, tiotropium, within the lungs of dosed rats, using systematic point by point MS and MS/MS sampling at 200 µm intervals. By comparing drug ion distribution patterns in adjacent tissue sections, we observed that within 15 min following exposure, tiotropium parent MS ions (mass-to-charge; m/z 392.1) and fragmented daughter MS/MS ions (m/z 170.1 and 152.1) were dispersed in a concentration gradient (80 fmol-5 pmol) away from the central airways into the lung parenchyma and pleura. These drug levels agreed well with amounts detected in lung compartments by chemical extraction. Moreover, the simultaneous global definition of molecular ion signatures localized within 2-D tissue space provides accurate assignment of ion identities within histological landmarks, providing context to dynamic biological processes occurring at sites of drug presence. Our results highlight an important emerging technology allowing specific high resolution identification of unlabeled drugs at sites of in vivo uptake and retention.  相似文献   
9.
Nonspecific adhesiveness of lymphocytes to polyacrylonitrile fiber and the antigen-specific adhesiveness of T-lymphocytes to Shigella flexneri pellicular immunosorbent have been studied in dysentery patients. Short courses of treatment with indomethacin, but not with thymalin (the preparation of thymic hormones), used for immunomodulation, have accelerated the normalization of nonspecific lymphocyte adhesiveness during regression of the disease, while indomethacin, in contrast to thymalin, inhibits antigen-specific T-lymphocyte adhesiveness which increases with the development of immune response.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号